{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T04:33:02Z","timestamp":1793334782248,"version":"4.5.0"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1007\/s00520-026-10746-3","type":"journal-article","created":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T12:38:14Z","timestamp":1777898294000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Sexual health among patients with breast cancer undergoing endocrine therapy: an integrative review"],"prefix":"10.1007","volume":"34","author":[{"given":"Xiaojing","family":"Su","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuefen","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sally","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Hua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anqi","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuehan","family":"Lian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qu","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiemin","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,4]]},"reference":[{"issue":"3","key":"10746_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I et al (2024) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 74(3):229\u2013263. https:\/\/doi.org\/10.3322\/caac.21834","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"10746_CR2","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1001\/jama.2018.19323","volume":"321","author":"AG Waks","year":"2019","unstructured":"Waks AG, Winer EP (2019) Breast cancer treatment: a review. JAMA 321(3):288\u2013300. https:\/\/doi.org\/10.1001\/jama.2018.19323","journal-title":"JAMA"},{"issue":"3","key":"10746_CR3","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/S1470-2045(21)00758-0","volume":"23","author":"R Bradley","year":"2022","unstructured":"Bradley R, Braybrooke J, Gray R, Hills RK, Liu Z, Pan H et al (2022) Aromatase inhibitors versus tamoxifen in premenopausal women with oestrogen receptor-positive early-stage breast cancer treated with ovarian suppression: a patient-level meta-analysis of 7030 women from four randomised trials. Lancet Oncol 23(3):382\u2013392. https:\/\/doi.org\/10.1016\/S1470-2045(21)00758-0","journal-title":"Lancet Oncol"},{"issue":"Suppl 3","key":"10746_CR4","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1111\/j.1743-6109.2005.00129.x","volume":"2","author":"A Graziottin","year":"2005","unstructured":"Graziottin A, Leiblum SR (2005) Biological and psychosocial pathophysiology of female sexual dysfunction during the menopausal transition. J Sex Med 2(Suppl 3):133\u2013145. https:\/\/doi.org\/10.1111\/j.1743-6109.2005.00129.x","journal-title":"J Sex Med"},{"key":"10746_CR5","unstructured":"World Health Organization (2006) Defi ning sexual health: report of a technical consultation on sexual health, 28-31 January2002, Geneva. Geneva: World Health Organization"},{"issue":"4","key":"10746_CR6","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-025-09352-6","volume":"33","author":"N Rodrigues-Machado","year":"2025","unstructured":"Rodrigues-Machado N, Bonfill-Cosp X, Quintana MJ, Santero M, B\u00e1rtolo A, Olid AS (2025) Sexual dysfunction in women with breast cancer: a systematic review. Support Care Cancer 33(4):332. https:\/\/doi.org\/10.1007\/s00520-025-09352-6","journal-title":"Support Care Cancer"},{"issue":"6","key":"10746_CR7","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1016\/j.ajog.2016.07.045","volume":"215","author":"J Gandhi","year":"2016","unstructured":"Gandhi J, Chen A, Dagur G, Suh Y, Smith N, Cali B et al (2016) Genitourinary syndrome of menopause: an overview of clinical manifestations, pathophysiology, etiology, evaluation, and management. Am J Obstet Gynecol 215(6):704\u2013711. https:\/\/doi.org\/10.1016\/j.ajog.2016.07.045","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"10746_CR8","doi-asserted-by":"publisher","DOI":"10.1155\/2023\/2636911","volume":"2023","author":"S Angl\u00e8s-Acedo","year":"2023","unstructured":"Angl\u00e8s-Acedo S, Mension E, Ribera-Torres L, G\u00f3mez Carballo S, Matas I, Tortajada M et al (2023) Breast cancer survivors with genitourinary syndrome of menopause receiving aromatase inhibitors are willing to sexual assessment: is a dyspareunia approach enough? Eur J Cancer Care 2023(1):2636911. https:\/\/doi.org\/10.1155\/2023\/2636911","journal-title":"Eur J Cancer Care"},{"issue":"3","key":"10746_CR9","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1007\/s10549-022-06750-w","volume":"196","author":"N Verma","year":"2022","unstructured":"Verma N, Blackford AL, Thorner E, Lehman J, Snyder C, Stearns V et al (2022) Factors associated with worsening sexual function during adjuvant endocrine therapy in a prospective clinic-based cohort of women with early-stage breast cancer. Breast Cancer Res Treat 196(3):535\u2013547. https:\/\/doi.org\/10.1007\/s10549-022-06750-w","journal-title":"Breast Cancer Res Treat"},{"issue":"10","key":"10746_CR10","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1038\/sj.bjc.6600294","volume":"86","author":"MJ Mourits","year":"2002","unstructured":"Mourits MJ, Bockermann I, De Vries EG, Van der Zee AG, Ten Hoor KA, Van der Graaf WT et al (2002) Tamoxifen effects on subjective and psychosexual well-being, in a randomised breast cancer study comparing high-dose and standard-dose chemotherapy. Br J Cancer 86(10):1546\u20131550. https:\/\/doi.org\/10.1038\/sj.bjc.6600294","journal-title":"Br J Cancer"},{"issue":"1","key":"10746_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4274\/ejbh.galenos.2023.2023-11-4","volume":"20","author":"NV Demircan","year":"2024","unstructured":"Demircan NV, Bese N (2024) New approaches in breast cancer radiotherapy. Eur J Breast Health 20(1):1\u20137. https:\/\/doi.org\/10.4274\/ejbh.galenos.2023.2023-11-4","journal-title":"Eur J Breast Health"},{"issue":"4","key":"10746_CR12","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1159\/000510079","volume":"16","author":"DM Lubi\u00e1n L\u00f3pez","year":"2021","unstructured":"Lubi\u00e1n L\u00f3pez DM, Butr\u00f3n Hinojo CA, S\u00e1nchez-Prieto M, Mendoza N, S\u00e1nchez-Borrego R (2021) Sexual dysfunction in postmenopausal women with breast cancer on adjuvant aromatase inhibitor therapy. Breast Care 16(4):376\u2013382. https:\/\/doi.org\/10.1159\/000510079","journal-title":"Breast Care"},{"issue":"2","key":"10746_CR13","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1097\/gme.0b013e31826560da","volume":"20","author":"J Baumgart","year":"2013","unstructured":"Baumgart J, Nilsson K, Evers AS, Kallak TK, Poromaa IS (2013) Sexual dysfunction in women on adjuvant endocrine therapy after breast cancer. Menopause 20(2):162\u2013168. https:\/\/doi.org\/10.1097\/gme.0b013e31826560da","journal-title":"Menopause"},{"issue":"12","key":"10746_CR14","doi-asserted-by":"publisher","first-page":"3102","DOI":"10.1111\/jsm.12684","volume":"11","author":"LR Schover","year":"2014","unstructured":"Schover LR, Baum GP, Fuson LA, Brewster A, Melhem\u2010Bertrandt A (2014) Sexual problems during the first 2 years of adjuvant treatment with aromatase inhibitors. J Sex Med 11(12):3102\u20133111. https:\/\/doi.org\/10.1111\/jsm.12684","journal-title":"J Sex Med"},{"key":"10746_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2024.1462722","volume":"12","author":"J Jin","year":"2024","unstructured":"Jin J, Han Y (2024) Understanding cultural perceptions of sexuality in China and their influence on human papillomavirus vaccine hesitancy. Front Public Health 12:1462722. https:\/\/doi.org\/10.3389\/fpubh.2024.1462722","journal-title":"Front Public Health"},{"issue":"3","key":"10746_CR16","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.sxmr.2022.02.001","volume":"10","author":"F Luo","year":"2022","unstructured":"Luo F, Link M, Grabenhorst C, Lynn B (2022) Low sexual desire in breast cancer survivors and patients: a review. Sex Med Rev 10(3):367\u2013375. https:\/\/doi.org\/10.1016\/j.sxmr.2022.02.001","journal-title":"Sex Med Rev"},{"key":"10746_CR17","doi-asserted-by":"publisher","DOI":"10.29289\/2594539420220034","author":"ET Cerigatto","year":"2023","unstructured":"Cerigatto ET, Moreira CCR, Andrade DPd, Morosini PNS, Czepula A (2023) Hormone therapy in the treatment of breast cancer and main outcomes in sexuality. Mastology. https:\/\/doi.org\/10.29289\/2594539420220034","journal-title":"Mastology"},{"issue":"2","key":"10746_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/ecc.12820","volume":"27","author":"M Sousa","year":"2018","unstructured":"Sousa M, Peate M, Lewis C, Jarvis S, Willis A, Hickey M et al (2018) Exploring knowledge, attitudes and experience of genitourinary symptoms in women with early breast cancer on adjuvant endocrine therapy. Eur J Cancer Care 27(2):1. https:\/\/doi.org\/10.1111\/ecc.12820","journal-title":"Eur J Cancer Care"},{"key":"10746_CR19","doi-asserted-by":"publisher","DOI":"10.1177\/11782234221145440","author":"A Johnsson","year":"2023","unstructured":"Johnsson A, Fugl-Meyer K, Bordas P, \u00c5hman J, Von Wachenfeldt A (2023) Side effects and its management in adjuvant endocrine therapy for breast cancer: a matter of communication and counseling. Breast Cancer: Basic & Clinical Research. https:\/\/doi.org\/10.1177\/11782234221145440","journal-title":"Breast Cancer: Basic & Clinical Research"},{"key":"10746_CR20","doi-asserted-by":"publisher","DOI":"10.1007\/s11764-023-01511-0","author":"JN Anderson","year":"2023","unstructured":"Anderson JN, Paladino AJ, Blue R, Dangerfield DT Ii, Eggly S, Martin MY et al (2023) Silent suffering: the impact of sexual health challenges on patient-clinician communication and adherence to adjuvant endocrine therapy among Black women with early-stage breast cancer. J Cancer Surviv. https:\/\/doi.org\/10.1007\/s11764-023-01511-0","journal-title":"J Cancer Surviv"},{"issue":"3","key":"10746_CR21","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.jncc.2025.02.002","volume":"5","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Ji Y, Liu S, Li J, Wu J, Jin Q et al (2025) Global burden of female breast cancer: new estimates in 2022, temporal trend and future projections up to 2050 based on the latest release from GLOBOCAN. J Natl Cancer Cent 5(3):287\u2013296. https:\/\/doi.org\/10.1016\/j.jncc.2025.02.002","journal-title":"J Natl Cancer Cent"},{"issue":"5","key":"10746_CR22","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1111\/j.1365-2648.2005.03621.x","volume":"52","author":"R Whittemore","year":"2005","unstructured":"Whittemore R, Knafl K (2005) The integrative review: updated methodology. J Adv Nurs 52(5):546\u2013553. https:\/\/doi.org\/10.1111\/j.1365-2648.2005.03621.x","journal-title":"J Adv Nurs"},{"key":"10746_CR23","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.b2535","volume":"339","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 339:b2535. https:\/\/doi.org\/10.1136\/bmj.b2535","journal-title":"BMJ"},{"issue":"3","key":"10746_CR24","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1111\/jep.12884","volume":"24","author":"QN Hong","year":"2018","unstructured":"Hong QN, Gonzalez-Reyes A, Pluye P (2018) Improving the usefulness of a tool for appraising the quality of qualitative, quantitative and mixed methods studies, the Mixed Methods Appraisal Tool (MMAT). J Eval Clin Pract 24(3):459\u2013467. https:\/\/doi.org\/10.1111\/jep.12884","journal-title":"J Eval Clin Pract"},{"issue":"6","key":"10746_CR25","doi-asserted-by":"publisher","first-page":"E670","DOI":"10.1097\/ncc.0000000000000981","volume":"44","author":"J Liu","year":"2021","unstructured":"Liu J, Hunter S, Zhu J, Lee RLT, Chan SW (2021) Decision-making experience related to mastectomy among women with breast cancer: an integrative review. Cancer Nurs 44(6):E670\u2013E686. https:\/\/doi.org\/10.1097\/ncc.0000000000000981","journal-title":"Cancer Nurs"},{"issue":"5","key":"10746_CR26","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.outlook.2006.06.004","volume":"54","author":"M Grey","year":"2006","unstructured":"Grey M, Knafl K, McCorkle R (2006) A framework for the study of self- and family management of chronic conditions. Nurs Outlook 54(5):278\u2013286. https:\/\/doi.org\/10.1016\/j.outlook.2006.06.004","journal-title":"Nurs Outlook"},{"key":"10746_CR27","doi-asserted-by":"publisher","unstructured":"Cella D, Fallowfield L, Barker P, Cuzick J, Locker G, Howell A et al (2006) Quality of life of postmenopausal women in the ATAC (\u201cArimidex\u201d, tamoxifen, alone or in combination) trial after completion of 5 years\u2019 adjuvant treatment for early breast cancer. Breast Cancer Res Treat 100(3):273\u201384. https:\/\/doi.org\/10.1007\/s10549-006-9260-6","DOI":"10.1007\/s10549-006-9260-6"},{"issue":"2","key":"10746_CR28","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1007\/s10549-020-05622-5","volume":"181","author":"K Ribi","year":"2020","unstructured":"Ribi K, Luo W, Walley BA, Burstein HJ, Chirgwin J, Ansari RH et al (2020) Treatment-induced symptoms, depression and age as predictors of sexual problems in premenopausal women with early breast cancer receiving adjuvant endocrine therapy. Breast Cancer Res Treat 181(2):347\u2013359. https:\/\/doi.org\/10.1007\/s10549-020-05622-5","journal-title":"Breast Cancer Res Treat"},{"key":"10746_CR29","doi-asserted-by":"publisher","unstructured":"Fallowfield L, Cella D, Cuzick L, Francis S, Locker G, Howell A (2004) Quality of life of postmenopausal women in the Arimidex, Tamoxifen, Alone or in Combination (ATAC) Adjuvant Breast Cancer Trial. J Clin Oncol 22(21):4261\u201371. https:\/\/doi.org\/10.1200\/JCO.2004.08.029","DOI":"10.1200\/JCO.2004.08.029"},{"key":"10746_CR30","doi-asserted-by":"publisher","unstructured":"Fallowfield L, Bliss JM, Porter LS, Price MH, Snowdon CF, Jones SE et al (2006) Quality of life in the Intergroup Exemestane Study: a randomized trial of exemestane versus continued tamoxifen after 2 to 3 years of tamoxifen in postmenopausal women with primary breast cancer. J Clin Oncol 24(6):910\u20137. https:\/\/doi.org\/10.1200\/JCO.2005.03.3654","DOI":"10.1200\/JCO.2005.03.3654"},{"key":"10746_CR31","doi-asserted-by":"publisher","unstructured":"Chen Z, Yongbin W, Quan Z, Yejuan Z, Qianming X, Qian Z (2023) Sexual function and sexual activity status of postoperative breast cancer patients and factors affecting them. Chr Pathematol J 24(03):369\u201374. https:\/\/doi.org\/10.16440\/j.Cnki.1674-8166.2023.03.11","DOI":"10.16440\/j.Cnki.1674-8166.2023.03.11"},{"issue":"05","key":"10746_CR32","first-page":"411","volume":"24","author":"H W","year":"2016","unstructured":"Haiyan W (2016) An investigative study on the effect of adjuvant endocrine therapy on sexual function in postmenopausal breast cancer patients. Tianjin J Nurs 24(05):411\u2013412","journal-title":"Tianjin J Nurs"},{"issue":"05","key":"10746_CR33","first-page":"558","volume":"14","author":"Q Glf","year":"2022","unstructured":"Qiong GLF (2022) Status and influencing factors of sexual dysfunction in young breast cancer patients during endocrine therapy. Chin J of Oncol Prev and Treat 14(05):558\u2013564","journal-title":"Chin J of Oncol Prev and Treat"},{"issue":"05","key":"10746_CR34","first-page":"737","volume":"56","author":"JW Feng","year":"2021","unstructured":"Feng JW, X J, Q L, T L, X YH (2021) Symptoms and its influencing factors among breast cancer survivors undergoing adjuvant endocrine therapy. Chin J Nurs 56(05):737\u2013743","journal-title":"Chin J Nurs"},{"issue":"4","key":"10746_CR35","doi-asserted-by":"publisher","first-page":"4428","DOI":"10.21037\/apm-21-352","volume":"10","author":"A Qi","year":"2021","unstructured":"Qi A, Li Y, Sun H, Jiao H, Liu Y, Chen Y (2021) Incidence and risk factors of sexual dysfunction in young breast cancer survivors. Ann Palliat Med 10(4):4428\u20134434. https:\/\/doi.org\/10.21037\/apm-21-352","journal-title":"Ann Palliat Med"},{"key":"10746_CR36","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2023.1218369","volume":"10","author":"L Gan","year":"2023","unstructured":"Gan L, Miao YM, Dong XJ, Zhang QR, Ren Q, Zhang N (2023) Investigation on sexual function in young breast cancer patients during endocrine therapy: a latent class analysis. Front Med (Lausanne) 10:1218369. https:\/\/doi.org\/10.3389\/fmed.2023.1218369","journal-title":"Front Med (Lausanne)"},{"issue":"4","key":"10746_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.soncn.2023.151443","volume":"39","author":"J Feng","year":"2023","unstructured":"Feng J, Zheng Z, Jiajia Q, Lichen T, Lei X, Weijie X et al (2023) Symptom clusters and quality of life in patients with breast cancer receiving endocrine therapy in China. Semin Oncol Nurs 39(4):151443. https:\/\/doi.org\/10.1016\/j.soncn.2023.151443","journal-title":"Semin Oncol Nurs"},{"issue":"11","key":"10746_CR38","doi-asserted-by":"publisher","first-page":"2788","DOI":"10.1200\/JCO.2001.19.11.2788","volume":"19","author":"G Berglund","year":"2001","unstructured":"Berglund G, Nystedt M, Bolund C, Sj\u00f6d\u00e9n PO, Rutquist LE (2001) Effect of endocrine treatment on sexuality in premenopausal breast cancer patients: a prospective randomized study. J Clin Oncol 19(11):2788\u20132796. https:\/\/doi.org\/10.1200\/JCO.2001.19.11.2788","journal-title":"J Clin Oncol"},{"issue":"10021","key":"10746_CR39","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/S0140-6736(15)01169-1","volume":"387","author":"PA Ganz","year":"2016","unstructured":"Ganz PA, Cecchini RS, Julian TB, Margolese RG, Costantino JP, Vallow LA et al (2016) Patient-reported outcomes with anastrozole versus tamoxifen for postmenopausal patients with ductal carcinoma in situ treated with lumpectomy plus radiotherapy (NSABP B-35): a randomised, double-blind, phase 3 clinical trial. The Lancet 387(10021):857\u2013865. https:\/\/doi.org\/10.1016\/S0140-6736(15)01169-1","journal-title":"The Lancet"},{"issue":"35","key":"10746_CR40","doi-asserted-by":"publisher","first-page":"3948","DOI":"10.1200\/JCO.2014.55.6993","volume":"32","author":"AJ Tevaarwerk","year":"2014","unstructured":"Tevaarwerk AJ, Wang M, Zhao F, Fetting JH, Cella D, Wagner LI et al (2014) Phase III comparison of tamoxifen versus tamoxifen plus ovarian function suppression in premenopausal women with node-negative, hormone receptor-positive breast cancer (E-3193, INT-0142): a trial of the Eastern Cooperative Oncology Group. J Clin Oncol 32(35):3948\u20133958. https:\/\/doi.org\/10.1200\/JCO.2014.55.6993","journal-title":"J Clin Oncol"},{"key":"10746_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.maturitas.2024.108143","volume":"191","author":"G Asinaro","year":"2025","unstructured":"Asinaro G, Massarotti C, Xholli A, Londero AP, Lambertini M, Anserini P et al (2025) Menopausal symptoms in breast cancer survivors on adjuvant endocrine therapy compared with those of menopausal women. Maturitas 191:108143. https:\/\/doi.org\/10.1016\/j.maturitas.2024.108143","journal-title":"Maturitas"},{"key":"10746_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.17784\/mtprehabjournal.2017.15.462","volume":"15","author":"TM Albanaz da Concei\u00e7\u00e3o","year":"2017","unstructured":"Albanaz da Concei\u00e7\u00e3o TM, Da Roza T, dos Santos KM, Tonon da Luz SC, Medeiros da Luz C (2017) Pelvic floor muscles contraction and sexual function are associated with hormonal treatment in women after breast cancer? Man Ther Posturol Rehabil J 15:1\u20135. https:\/\/doi.org\/10.17784\/mtprehabjournal.2017.15.462","journal-title":"Man Ther Posturol Rehabil J"},{"issue":"1","key":"10746_CR43","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1080\/0284186X.2020.1813326","volume":"60","author":"M Fogh","year":"2021","unstructured":"Fogh M, H\u00f8jgaard A, Rotb\u00f8l CB, Jensen AB (2021) The majority of Danish breast cancer survivors on adjuvant endocrine therapy have clinically relevant sexual dysfunction: a cross-sectional study. Acta Oncol 60(1):61\u201368. https:\/\/doi.org\/10.1080\/0284186X.2020.1813326","journal-title":"Acta Oncol"},{"key":"10746_CR44","doi-asserted-by":"publisher","unstructured":"van Londen GJ, Beckjord EB, Dew MA, Cooper KL, Davidson NE, Bovbjerg DH et al (2014) Associations between adjuvant endocrine therapy and onset of physical and emotional concerns among breast cancer survivors. Support Care Cancer 22(4):937\u201345. https:\/\/doi.org\/10.1007\/s00520-013-2041-y","DOI":"10.1007\/s00520-013-2041-y"},{"issue":"3","key":"10746_CR45","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1007\/s12020-017-1470-7","volume":"60","author":"A Gambardella","year":"2018","unstructured":"Gambardella A, Esposito D, Accardo G, Taddeo M, Letizia A, Tagliafierro R et al (2018) Sexual function and sex hormones in breast cancer patients. Endocrine 60(3):510\u2013515. https:\/\/doi.org\/10.1007\/s12020-017-1470-7","journal-title":"Endocrine"},{"issue":"6","key":"10746_CR46","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1002\/pon.3130","volume":"22","author":"MR Safarinejad","year":"2013","unstructured":"Safarinejad MR, Shafiei N, Safarinejad S (2013) Quality of life and sexual functioning in young women with early-stage breast cancer 1\u2009year after lumpectomy. Psychooncology 22(6):1242\u20131248. https:\/\/doi.org\/10.1002\/pon.3130","journal-title":"Psychooncology"},{"issue":"1","key":"10746_CR47","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s10549-013-2659-y","volume":"141","author":"D Frechette","year":"2013","unstructured":"Frechette D, Paquet L, Verma S, Clemons M, Wheatley-Price P, Gertler SZ et al (2013) The impact of endocrine therapy on sexual dysfunction in postmenopausal women with early stage breast cancer: encouraging results from a prospective study. Breast Cancer Res Treat 141(1):111\u2013117. https:\/\/doi.org\/10.1007\/s10549-013-2659-y","journal-title":"Breast Cancer Res Treat"},{"issue":"28","key":"10746_CR48","doi-asserted-by":"publisher","first-page":"6931","DOI":"10.1200\/JCO.2005.11.181","volume":"23","author":"TJ Whelan","year":"2005","unstructured":"Whelan TJ, Goss PE, Ingle JN, Pater JL, Tu D, Pritchard K et al (2005) Assessment of quality of life in MA.17: a randomized, placebo-controlled trial of letrozole after 5 years of tamoxifen in postmenopausal women. J Clin Oncol 23(28):6931\u20136940. https:\/\/doi.org\/10.1200\/JCO.2005.11.181","journal-title":"J Clin Oncol"},{"issue":"5","key":"10746_CR49","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1200\/JCO.1999.17.5.1488","volume":"17","author":"JE Mortimer","year":"1999","unstructured":"Mortimer JE, Boucher L, Baty J, Knapp DL, Ryan E, Rowland JH (1999) Effect of tamoxifen on sexual functioning in patients with breast cancer. J Clin Oncol 17(5):1488\u20131492","journal-title":"J Clin Oncol"},{"issue":"2","key":"10746_CR50","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1007\/s10549-023-06981-5","volume":"200","author":"K Bryl","year":"2023","unstructured":"Bryl K, Chimonas S, Li X, Li SQ, Mao JJ (2023) The relationship between anxiety and vaginal-related sexual health in postmenopausal breast cancer survivors on aromatase inhibitors therapies: a cross sectional study. Breast Cancer Res Treat 200(2):257\u2013264. https:\/\/doi.org\/10.1007\/s10549-023-06981-5","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"10746_CR51","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1007\/s10549-022-06808-9","volume":"198","author":"A Carmen","year":"2023","unstructured":"Carmen A, Anne O, Monika S, Daniel E, Johannes G, Verena M et al (2023) Does the toxicity of endocrine therapy persist into long-term survivorship?: Patient-reported outcome results from a follow-up study beyond a 10-year-survival. Breast Cancer Res Treat 198(3):475\u2013485. https:\/\/doi.org\/10.1007\/s10549-022-06808-9","journal-title":"Breast Cancer Res Treat"},{"issue":"2","key":"10746_CR52","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1007\/s10549-011-1378-5","volume":"128","author":"A Oberguggenberger","year":"2011","unstructured":"Oberguggenberger A, Hubalek M, Sztankay M, Meraner V, Beer B, Oberacher H et al (2011) Is the toxicity of adjuvant aromatase inhibitor therapy underestimated? Complementary information from patient-reported outcomes (PROs). Breast Cancer Res Treat 128(2):553\u2013561. https:\/\/doi.org\/10.1007\/s10549-011-1378-5","journal-title":"Breast Cancer Res Treat"},{"issue":"4","key":"10746_CR53","doi-asserted-by":"publisher","first-page":"3633","DOI":"10.1007\/s00520-022-06810-3","volume":"30","author":"A Bobrie","year":"2022","unstructured":"Bobrie A, Jarlier M, Moussion A, Jacot W, D\u2019Hondt V (2022) Sexual quality of life assessment in young women with breast cancer during adjuvant endocrine therapy and patient-reported supportive measures. Support Care Cancer 30(4):3633\u20133641. https:\/\/doi.org\/10.1007\/s00520-022-06810-3","journal-title":"Support Care Cancer"},{"issue":"8","key":"10746_CR54","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1097\/00001813-200409000-00003","volume":"15","author":"L Morales","year":"2004","unstructured":"Morales L, Neven P, Timmerman D, Christiaens M-R, Vergote I, Van Limbergen E et al (2004) Acute effects of tamoxifen and third-generation aromatase inhibitors on menopausal symptoms of breast cancer patients. Anti Cancer Drugs 15(8):753\u2013760. https:\/\/doi.org\/10.1097\/00001813-200409000-00003","journal-title":"Anti Cancer Drugs"},{"issue":"5","key":"10746_CR55","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1093\/annonc\/mdl030","volume":"17","author":"A Glaus","year":"2006","unstructured":"Glaus A, Boehme C, Th\u00fcrlimann B, Ruhstaller T, Hsu Schmitz SF, Morant R et al (2006) Fatigue and menopausal symptoms in women with breast cancer undergoing hormonal cancer treatment. Ann Oncol 17(5):801\u2013806. https:\/\/doi.org\/10.1093\/annonc\/mdl030","journal-title":"Ann Oncol"},{"issue":"3","key":"10746_CR56","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1007\/s10549-023-07054-3","volume":"201","author":"M Faltinova","year":"2023","unstructured":"Faltinova M, Vehmanen L, Lyytinen H, Haanpaa M, Hamalainen E, Tiitinen A et al (2023) Effects of letrozole on serum estradiol and estrone in postmenopausal breast cancer patients and tolerability of treatment: a prospective trial using a highly sensitive LC-MS\/MS (liquid chromatography-tandem mass spectrometry) method for estrogen measurement. Breast Cancer Res Treat 201(3):425\u2013435. https:\/\/doi.org\/10.1007\/s10549-023-07054-3","journal-title":"Breast Cancer Res Treat"},{"issue":"11","key":"10746_CR57","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1007\/s10552-016-0810-x","volume":"27","author":"SN Landi","year":"2016","unstructured":"Landi SN, Doll KM, Bensen JT, Hendrix L, Anders CK, Wu JM et al (2016) Endocrine therapy and urogenital outcomes among women with a breast cancer diagnosis. Cancer Causes Control 27(11):1325\u20131332. https:\/\/doi.org\/10.1007\/s10552-016-0810-x","journal-title":"Cancer Causes Control"},{"issue":"4","key":"10746_CR58","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1007\/s00520-019-04667-7","volume":"27","author":"L Jing","year":"2019","unstructured":"Jing L, Zhang C, Li W, Jin F, Wang A (2019) Incidence and severity of sexual dysfunction among women with breast cancer: a meta-analysis based on Female Sexual Function Index. Support Care Cancer 27(4):1171\u20131180. https:\/\/doi.org\/10.1007\/s00520-019-04667-7","journal-title":"Support Care Cancer"},{"issue":"3","key":"10746_CR59","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.ajog.2024.10.054","volume":"232","author":"ME Beste","year":"2025","unstructured":"Beste ME, Kaunitz AM, McKinney JA, Sanchez-Ramos L (2025) Vaginal estrogen use in breast cancer survivors: a systematic review and meta-analysis of recurrence and mortality risks. Am J Obstet Gynecol 232(3):262\u201370.e1. https:\/\/doi.org\/10.1016\/j.ajog.2024.10.054","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"10746_CR60","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1007\/s11764-022-01319-4","volume":"17","author":"SMW Jones","year":"2023","unstructured":"Jones SMW, Ton M, Heffner JL, Malen RC, Cohen SA, Newcomb PA (2023) Association of financial worry with substance use, mental health, and quality of life in cancer patients. J Cancer Surviv 17(6):1824\u20131833. https:\/\/doi.org\/10.1007\/s11764-022-01319-4","journal-title":"J Cancer Surviv"},{"key":"10746_CR61","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgh-2024-017133","author":"TA Kitaw","year":"2025","unstructured":"Kitaw TA, Tilahun BD, Zemariam AB, Getie A, Bizuayehu MA, Haile RN (2025) The financial toxicity of cancer: unveiling global burden and risk factors - a systematic review and meta-analysis. BMJ Glob Health. https:\/\/doi.org\/10.1136\/bmjgh-2024-017133","journal-title":"BMJ Glob Health"},{"key":"10746_CR62","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyg.2022.864893","author":"JB Reese","year":"2022","unstructured":"Reese JB, Zimmaro LA, McIlhenny S, Sorice K, Porter LS, Zaleta AK et al (2022) Coping with changes to sex and intimacy after a diagnosis of metastatic breast cancer: results from a qualitative investigation with patients and partners. Front Psychol. https:\/\/doi.org\/10.3389\/fpsyg.2022.864893","journal-title":"Front Psychol"},{"issue":"2","key":"10746_CR63","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1007\/s00520-018-4369-9","volume":"27","author":"MR Canzona","year":"2019","unstructured":"Canzona MR, Fisher CL, Ledford CJW (2019) Perpetuating the cycle of silence: the intersection of uncertainty and sexual health communication among couples after breast cancer treatment. Support Care Cancer 27(2):659\u2013668. https:\/\/doi.org\/10.1007\/s00520-018-4369-9","journal-title":"Support Care Cancer"},{"issue":"10","key":"10746_CR64","doi-asserted-by":"publisher","first-page":"3159","DOI":"10.1245\/s10434-019-07552-z","volume":"26","author":"R Kuehn","year":"2019","unstructured":"Kuehn R, Casaubon J, Raker C, Edmonson D, Stuckey A, Gass J (2019) Sexual dysfunction in survivorship; the impact of menopause and endocrine therapy. Ann Surg Oncol 26(10):3159\u20133165. https:\/\/doi.org\/10.1245\/s10434-019-07552-z","journal-title":"Ann Surg Oncol"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-026-10746-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-026-10746-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-026-10746-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T04:24:02Z","timestamp":1793334242000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-026-10746-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":64,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["10746"],"URL":"https:\/\/doi.org\/10.1007\/s00520-026-10746-3","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"28 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The correct funding should be: This study was funded by the National Natural Science Foundation of China (Grant No. 72361167634), not by Grant No. 7231101009. The original article has been updated accordingly.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was funded by National Natural Science Foundation of China (7231101009). The authors declare that they have no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"495"}}